Article · 31 Mar 2025
Research articlePublished 2013
Prospective Randomized Controlled Trial of Nimodipine as Add-On Therapy in the Treatment of Focal Refractory Epilepsy Patients: A Pilot Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: To prove whether the use of nimodipine as add-on therapy in focal refractory epilepsy patients could improve seizure control and quality of life. Methods: This is a randomized, unblinded, controlled trial of nimodipine as add-on therapy in adult patients with focal refractory epilepsy. The trial consisted of baseline, maintenance and taper periods. Twenty-two patients with focal refractory epilepsy, which seizure frequency was greater than 5 per month, were randomized to one of the following dosage treatment regimens of nimodipine administered orally in four subdoses and according to body weight: arm A, 2 mg/kg/day; arm B, 3 mg/kg/day. The primary efficacy assessment, based on change in seizure frequency, was evaluated in two ways: the 50% responder rate and seizure freedom from baseline to maintenance periods; quality of life improvement was also taken into consideration. Assessment of adverse events (AEs) was included for safety evaluation. Results: In the intention to treat population, 7.6% of patients were seizure free for 3 months. In 16/26 patients (61.5%) seizure rate was reduced more than fifty percent. In the per protocol population 16/22 patients (72.7%) seizure rate also diminished more than fifty percent. In those patients allocated to the arm B, seizure frequency improved more than 50% in the first month of treatment. After three months of treatment, total quality of life improved significantly (p<0.05). The most frequently reported adverse events were somnolence and headache. Conclusion: Nimodipine improves quality of life and reduced seizure rate in patients with refractory focal epilepsy.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Neurology & Neurophysiology.
Conference abstract · 3 Feb 2025
The Most common cause of falls without cause in geriatric patients
Conference abstract · 3 Feb 2025
Neuroimaging by Evaluation Nerverenovate and Neuroplasticity of Acupuncture in Children with Cerebral Palsy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neurology & Neurophysiology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Rene Andrade Machado”
- BylineArticles whose byline prints “Edgar Bladimir Romero”
- BylineArticles whose byline prints “Adriana Maria Goicoechea Astencio”
- BylineArticles whose byline prints “Aisel Santos Santos”
- BylineArticles whose byline prints “Vanessa Benjumea Cuartas”
- BylineArticles whose byline prints “Marlene Maya Lopez”
